Alginate-coated magnetic nanoparticles for noninvasive MRI of extracellular calcium

NMR in Biomedicine

Volumn 27, Issue 7, 2014, Pages 774-783

  Bar Shir, Amnon ^a   Avram, Liat ^a   Yariv Shoushan, Shani ^a   Anaby, Debbie ^a   Cohen, Smadar ^b   Segev Amzaleg, Niva ^a   Frenkel, Dan ^a   Sadan, Ofer ^a   Offen, Daniel ^a   Cohen, Yoram ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Alginates; Calcium sensing; Contrast agents; Magnetic nanoparticles; Molecular MRI; MRI

Indexed keywords

ALGINATE; CELL CULTURE; HISTOLOGY; MAGNETIC RESONANCE IMAGING; MEDICAL APPLICATIONS; METAL IONS; NANOPARTICLES; TISSUE;

BIOMEDICAL APPLICATIONS; CONTRAST AGENT; CONTRAST MECHANISM; MAGNETIC NANO-PARTICLES; MOLECULAR MRIS; NANOPARTICLE (NPS); NONINVASIVE DETERMINATION; SUPERPARAMAGNETIC IRON OXIDES;

CALCIUM;

ALGINIC ACID; CALCIUM ION; PROTON; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; CALCIUM; GLUCURONIC ACID; HEXURONIC ACID; MAGNETITE NANOPARTICLE; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE CULTURE; CELL CULTURE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; MALE; MOLECULAR WEIGHT; MOUSE; NANOIMAGING; NEUROIMAGING; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUALITATIVE RESEARCH; REACTION TIME; ANIMAL; C57BL MOUSE; CELL SURVIVAL; CHEMISTRY; LIGHT; PROCEDURES; RADIATION SCATTERING; SIGNAL PROCESSING; TIME; WISTAR RAT;

ALGINATES; ANIMALS; CALCIUM; CELL SURVIVAL; GLUCURONIC ACID; HEXURONIC ACIDS; LIGHT; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MICE, INBRED C57BL; RATS, WISTAR; SCATTERING, RADIATION; SIGNAL PROCESSING, COMPUTER-ASSISTED; TIME FACTORS; WATER;

EID: 84902384432     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3117     Document Type: Article

References (51)

1. Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17: 484-499.
2. Mulder WJM, Strijkers GJ, van Tilborg GAF, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed. 2006; 19: 142-164.
3. Yoo D, Lee J-H, Shin T-H, Cheon J. Theranostic magnetic nanoparticles. Acc. Chem. Res. 2011; 44: 863-874.
4. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000; 1: 11-21.
5. Kumura E, Graf R, Dohmen C, Rosner G, Heiss W. Breakdown of calcium homeostasis in relation to tissue depolarization: comparison between gray and white matter ischemia. J. Cereb. Blood Flow Metab. 1999; 19: 788-793.
6. Somjen GG. Ions in the Brain: Normal Function, Seizures, and Stroke. Oxford University Press: New York, NY, USA; 2004.
7. Rochefort NL, Jia H, Konnerth A. Calcium imaging in the living brain: prospects for molecular medicine. Trends Mol. Med. 2008; 14: 389-399.
8. Lee S, Park K, Kim K, Choi K, Kwon IC. Activable imaging probes for fluorescent signals. Chem. Commun. 2008; 36: 4250-4260.
9. Helmchen F, Denk W. Deep tissue two-photon microscopy. Nat. Methods 2005; 2: 932-940.
10. Ohki K, Chung S, Ch'ng YH, Kara P, Reid RC. Functional imaging with cellular resolution reveals precise micro-architecture in visual cortex. Nature 2005; 433: 597-603.
11. Kerr JND, Greenberg D, Helmchen F. Imaging input and output of neocortical networks in vivo. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 14 063-14 068.
12. Stark DD, Bradley WG. Magnetic Resonance Imaging, 3rd edn. Mosby: St. Louis, MO, 1999.
13. Tofts P. Quantitative MRI of the Brain: Measuring Changes Caused by Disease. Wiley: Chichester, 2003.
14. Louie AY, Huber MM, Ahrens ET, Rothbacher U, Moats R, Jacobs RE, Fraser SE, Meade TJ. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 2000; 18: 321-325.
15. Westmeyer GG, Durocher Y, Jasanoff AA. Secreted enzyme reporter system for MRI. Angew. Chem. Int. Ed. 2010; 49: 3909-3911.
16. Frullano L, Wang C, Miller RH, Wang YA. Myelin-specific contrast agent for magnetic resonance imaging of myelination. J. Am. Chem. Soc. 2011; 133: 1611-1613.
17. De Leon-Rodriguez LM, Lubag AJM, Malloy CR, Martinez GV, Gillies RJ, Sherry AD. Responsive MRI agents for sensing metabolism in vivo. Acc. Chem. Res. 2009; 42: 948-957.
18. Lee JH, Huh YM, Jun Y, Seo J, Jang J, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 2006; 13: 95-99.
19. 1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells. J. Am. Chem. Soc. 2011; 133: 2955-2961.
20. Choi J-S, Lee J-H, Shin T-H, Song H-T, Kim EY, Cheon J. Self-confirming "AND" logic nanoparticles for fault-free MRI. J. Am. Chem. Soc. 2010; 132: 11 015-11 017.
21. Cheon J, Lee JH. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc. Chem. Res. 2008; 41: 1630-1640.
22. Que EL, Gianolio E, Baker SL, Wong AP, Aime S, Chang CJ. Copper-responsive magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 2009; 131: 8527-8536.
23. Que EL, Chang CJ. A smart magnetic resonance contrast agent for selective copper sensing. J. Am. Chem. Soc. 2006; 128: 15 942-15 943.
24. Zhang X, Lovejoy KS, Jasanoff A, Lippard SJ. Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing. Proc. Natl. Acad. Sci. U. S. A. 2007; 104: 10 780-10 785.
25. Major JL, Meade TJ. Bioresponsive, cell-penetrating, and multimeric MR contrast agents. Acc. Chem. Res. 2009; 42: 893-903.
26. Que EL, Chang CJ. Responsive magnetic resonance imaging contrast agents as chemical sensors for metals in biology and medicine. Chem. Soc. Rev. 2009; 39: 51-60.
27. Li W-H, Fraser SE, Meade TJ. A calcium-sensitive magnetic resonance imaging contrast agent. J. Am. Chem. Soc. 1999; 121: 1413-1414.
28. Li W-H, Parigi G, Fragai M, Luchinat C, Meade TJ. Mechanistic studies of a calcium-dependent MRI contrast agent. J. Inorg. Chem. 2002; 41; 4018-4024.
29. Dhingra K, Maier ME, Beyerlein M, Angelovski G, Logothetis NK. Synthesis and characterization of a smart contrast agent sensitive to calcium. Chem. Commun. 2008; 29: 3444-3446.
30. Angelovski G, Fouskova P, Mamedov I, Canals S, Toth E, Logothetis NK. Smart magnetic resonance imaging agents that sense extracellular calcium fluctuations. Chembiochem 2008; 9: 1729-1734.
31. 3+ complexes: an attempt towards calcium-sensitive MRI contrast agents. J. Inorg. Chem. 2008; 47: 1370-1381.
32. 3+ complexes. J. Biol. Inorg. Chem. 2008; 13: 35-46.
33. Mamedov I, Canals S, Henig JR, Beyerlein M, Murayama Y, Mayer HA, Logothetis NK, Angelovski G. In vivo characterization of a smart MRI agent that displays an inverse response to calcium concentration. ACS Chem. Neurosci. 2010; 1: 819-828.
34. Atanasijevic T, Shusteff M, Fam P, Jasanoff A. Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin. Proc. Natl. Acad. Sci. U. S. A. 2006; 103: 14 707-14 712.
35. Atanasijevic T, Jasanoff A. Preparation of iron oxide-based calcium sensors for MRI. Nat. Protocols 2007; 2: 2582-2589.
36. Angelovski G, Chauvin T, Pohmann R, Logothetis NK, Tóth É. Calcium-responsive paramagnetic CEST agents. Bioorg. Med. Chem. 2011; 19: 1097-1105.
37. Fang Y, Al-Assaf S, Phillips GO, Nishinari K, Funami T, Williams PA, Li L. Multiple steps and critical behaviors of the binding of calcium to alginate. J. Phys. Chem. B 2007; 111: 2456-2462.
38. Chen KL, Mylon SE, Elimelech M. Enhanced aggregation of alginate-coated iron oxide (hematite) nanoparticles in the presence of calcium, strontium, and barium cations. Langmuir 2007; 23: 5920-5928.
39. Chen KL, Mylon SE, Elimelech M. Aggregation kinetics of alginate-coated hematite nanoparticles in monovalent and divalent electrolytes. Environ. Sci. Technol. 2006; 40: 1516-1523.
40. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, Leor J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation 2008; 117: 1388-1396.
41. Tsur-Gang O, Ruvinov E, Landa N, Holbova R, Feinberg MS, Leor J, Cohen S. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials 2009; 30: 189-195.
42. Ma H-L, Qi X-R, Maitani Y, Nagai T. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int. J. Pharm. 2007; 333: 177-186.
43. Ma H-L, Xu YF, Qi X-R, Maitani Y, Nagai T. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int. J. Pharm. 2008; 354: 217-226.
44. Sadan O, Shemesh N, Barzilay R, Bahat-Stromza M, Melamed E, Cohen Y, Offen D. Migration of neurotrophic factor-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging. Stem Cells 2008; 26: 2542-2551.
45. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995-4021.
46. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 2008; 108: 2064-2110.
47. Mahmoudi M, Sahraian MA, Shokrgozar MA, Laurent S. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis. ACS Chem. Neurosci. 2011; 2: 118-140.
48. Tsuzuki K, Iino M, Ozawa S. Change in calcium permeability caused by quinolinic acid in cultured rat hippocampal neurons. Neurosci. Lett. 1989; 105: 269-274.
49. Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ. Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington's disease. Prog. Neurobiol. 2010; 90: 230-245.
50. 19F magnetic resonance imaging. J. Am. Chem. Soc. 2013; 135: 12 164-12 167.
51. Kim S, Park JW, Kim D, Kim D, Lee I-H, Jon S. Bioinspired colorimetric detection of calcium(II) ion in serum using calsequestrin-functionalized gold nanoparticles. Angew. Chem. Int. Ed. 2009; 48: 4138-4141.